Drug that skyrocketed 5,000% hasn't come down in price
Posted online
The drug that skyrocketed in price from $13.50 to $750 a pill has yet to come back down.
"We've agreed to lower the price of Daraprim to a price that is more affordable," Martin Shkreli, CEO of Turing Pharmaceuticals, said on ABC World News Tonight on Sept. 24. He did not specify a price or timeline.
Used by cancer and AIDS patients, the drug's price increase sparked a public outcry.
Utah-based gourmet cookie chain Crumbl Cookies opened its first Springfield shop; interior design business Branson Upstaging LLC relocated; and Lauren Ashley Dance Center LLC added a second location.